Corey A Siegel Selected Research

Immunologic Factors (Immunomodulators)

1/2021	Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review.
1/2019	Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
11/2018	Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All.
4/2016	Evaluating Study Withdrawal Among Biologics and Immunomodulators in Treating Ulcerative Colitis: A Meta-analysis of Controlled Clinical Trials.
12/2015	Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials.
8/2015	Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability.
9/2014	Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.
5/2013	Do inflammatory bowel disease therapies cause cancer?
1/2012	Adverse events do not outweigh benefits of combination therapy for Crohn's disease in a decision analytic model.
9/2011	The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Corey A Siegel Research Topics

Disease

39	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 07/2006
35	Crohn Disease (Crohn's Disease) 11/2022 - 08/2006
29	Ulcerative Colitis 10/2022 - 01/2009
15	Infections 11/2022 - 09/2007
11	Lymphoma (Lymphomas) 09/2014 - 08/2006
8	Neoplasms (Cancer) 01/2021 - 02/2009
4	Necrosis 01/2022 - 12/2014
4	Inflammation (Inflammations) 01/2022 - 07/2012
4	Colitis 01/2022 - 09/2011
3	Fistula 10/2022 - 09/2007
3	Hemorrhage 10/2020 - 10/2018
2	Abdominal Pain (Pain, Abdominal) 10/2022 - 01/2022
2	COVID-19 10/2020 - 10/2020
2	Colorectal Neoplasms (Colorectal Cancer) 04/2016 - 11/2010
2	Skin Neoplasms (Skin Cancer) 09/2014 - 05/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2013 - 08/2009
2	Progressive Multifocal Leukoencephalopathy 10/2010 - 09/2007
1	Wounds and Injuries (Trauma) 11/2022
1	Proctitis 11/2022
1	Ileitis 10/2022
1	Pouchitis 10/2022
1	Pathologic Constriction (Stenosis) 10/2022
1	Constipation 03/2022
1	Pain (Aches) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Headache (Headaches) 10/2020
1	Nausea 10/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020
1	Ulcer 01/2020
1	Hallucinations (Hallucination) 01/2018
1	Weight Gain 01/2018
1	Iron Deficiencies 01/2017
1	Anemia 01/2017
1	Injection Site Reaction 12/2015
1	Marijuana Use 02/2015
1	Human Influenza (Influenza) 08/2013
1	Disease Progression 05/2013
1	Rectal Diseases (Rectal Disease) 07/2012
1	Rheumatoid Arthritis 09/2011
1	Demyelinating Diseases (Demyelinating Disease) 09/2011
1	Tuberculosis (Tuberculoses) 09/2011

Drug/Important Bio-Agent (IBA)

19	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2009
15	Infliximab (Remicade)FDA Link 01/2021 - 08/2006
14	Pharmaceutical PreparationsIBA 11/2022 - 09/2011
14	Biological ProductsIBA 01/2022 - 10/2008
14	Immunologic Factors (Immunomodulators)IBA 01/2021 - 08/2009
13	vedolizumabIBA 01/2022 - 02/2015
8	SteroidsIBA 01/2022 - 09/2007
7	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 03/2013
7	Adalimumab (Humira)FDA Link 01/2021 - 03/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2010
4	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 02/2015
3	Azathioprine (Imuran)FDA LinkGeneric 01/2021 - 01/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2010
3	IntegrinsIBA 11/2018 - 09/2011
2	Budesonide (Pulmicort)FDA LinkGeneric 10/2022 - 01/2010
2	C-Reactive ProteinIBA 10/2022 - 10/2018
2	ImmunosorbentsIBA 01/2021 - 10/2019
2	SDMIBA 01/2021 - 09/2015
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2021 - 02/2015
2	AntibodiesIBA 01/2021 - 01/2016
2	EnzymesIBA 01/2021 - 10/2019
2	acceleratory factor from growth hormone (AcG)IBA 01/2019 - 01/2017
2	golimumab FDA Link 10/2018 - 01/2017
2	Methotrexate (Mexate)FDA LinkGeneric 02/2015 - 01/2010
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2014 - 02/2009
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	CytokinesIBA 01/2021
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2020
1	apremilastIBA 10/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 10/2018
1	andecaliximabIBA 08/2018
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2018
1	IronIBA 01/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Ferritins (Ferritin)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 12/2015
1	EndocannabinoidsIBA 02/2015
1	2-mercaptopurineIBA 09/2014
1	VaccinesIBA 08/2013
1	Suppositories (Vaginal Suppositories)IBA 07/2012
1	Natalizumab (Tysabri)FDA Link 09/2011

Therapy/Procedure

44	Therapeutics 11/2022 - 03/2005
10	Biological Therapy 10/2022 - 12/2010
7	Colectomy 10/2018 - 02/2009
3	Hyperbaric Oxygenation 01/2022 - 10/2018
1	Physical Therapy Modalities (Physical Therapy Technique) 03/2022
1	Medical Day Care (Partial Hospitalization) 01/2022
1	Patient Discharge 01/2022
1	Premedication 01/2017
1	Ileostomy 04/2016
1	Colonic Pouches (S Pouch) 01/2014
1	Ostomy 01/2014
1	Enema (Enemas) 07/2012